Literature DB >> 17448597

Marked gene transcript level alterations occur early during radical prostatectomy.

Thorsten Schlomm1, Esther Näkel, Andreas Lübke, Andreas Buness, Felix K-H Chun, Thomas Steuber, Markus Graefen, Ronald Simon, Guido Sauter, Annemarie Poustka, Hartwig Huland, Andreas Erbersdobler, Holger Sültmann, Olaf J C Hellwinkel.   

Abstract

OBJECTIVES: Gene expression analyses have become an important approach to understand the biology of cancer. However, transcript level patterns and RNA quality could rapidly change in response to ischemic and mechanical stress. Studies have shown that this occurs both perioperatively and after surgical removal of organs.
METHODS: To better understand the relative importance of perioperative and postoperative gene expression changes, we performed quantitative reverse transcription-polymerase chain reactions on the transcripts of 91 cancer-related genes from normal and cancerous prostate tissues from 10 patients at eight different time points during surgical manipulation and after removal of the prostate.
RESULTS: The mRNA levels of 8 (EGR1, p21, KRT17, PIM1, S100P, TNFRSF, WFDC2, and TRIM29) of 91 genes changed significantly with time of surgery in normal and tumor tissue. Remarkably, all eight genes were up-regulated, a reaction that was most prominent during the early intraoperative period. Additional changes occurred but were much less prominent during the first postoperative hour.
CONCLUSIONS: Our results substantially challenge the utility of immediate postoperative tissue sampling. At least for prostate cancer, the data suggest that preoperative tissue collection by core biopsies is optimal for studying molecular changes in normal and neoplastic prostate tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448597     DOI: 10.1016/j.eururo.2007.03.075

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  17 in total

1.  [Identification and validation of clinically relevant molecular alterations in prostate cancer].

Authors:  T Schlomm; H Sültmann; J Köllermann
Journal:  Urologe A       Date:  2008-09       Impact factor: 0.639

2.  [Identification and validation of clinically relevant molecular alterations in prostate cancer].

Authors:  T Schlomm; H Sültmann; J Köllermann
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

3.  Biological, Medical, and Other Tissue Variables Affecting Biospecimen Utilization.

Authors:  Dennis Otali; Sameer Al Diffalha; William E Grizzle
Journal:  Biopreserv Biobank       Date:  2019-06       Impact factor: 2.300

Review 4.  Biobanking in genomic medicine.

Authors:  Jane H Zhou; Aysegul A Sahin; Jeffrey N Myers
Journal:  Arch Pathol Lab Med       Date:  2015-06       Impact factor: 5.534

Review 5.  Effects of Cold Ischemia on Gene Expression: A Review and Commentary.

Authors:  William E Grizzle; Dennis Otali; Katherine C Sexton; Daniel S Atherton
Journal:  Biopreserv Biobank       Date:  2016-08-23       Impact factor: 2.300

6.  Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.

Authors:  Udo Rudloff; Umesh Bhanot; William Gerald; David S Klimstra; William R Jarnagin; Murray F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2010-02-17       Impact factor: 5.344

7.  Effect of surgical procedures on prostate tumor gene expression profiles.

Authors:  Jie Li; Zhi-Hong Zhang; Chang-Jun Yin; Christian Pavlovich; Jun Luo; Robert Getzenberg; Wei Zhang
Journal:  Asian J Androl       Date:  2012-08-06       Impact factor: 3.285

8.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.

Authors:  Carissa F Santos; John Kurhanewicz; Z Laura Tabatabai; Jeffry P Simko; Kayvan R Keshari; Akpene Gbegnon; Romelyn Delos Santos; Scot Federman; Katsuto Shinohara; Peter R Carroll; Christopher M Haqq; Mark G Swanson
Journal:  NMR Biomed       Date:  2009-12-23       Impact factor: 4.044

9.  Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies.

Authors:  Harveer Dev; David Rickman; Prasanna Sooriakumaran; Abhishek Srivastava; Sonal Grover; Robert Leung; Robert Kim; Naoki Kitabayashi; Raquel Esqueva; Kyung Park; Jessica Padilla; Mark Rubin; Ashutosh Tewari
Journal:  J Transl Med       Date:  2011-07-26       Impact factor: 5.531

10.  The surgical specimen is the personalized part of personalized cancer medicine.

Authors:  Carolyn C Compton
Journal:  Ann Surg Oncol       Date:  2009-05-27       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.